Cargando…
Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
BACKGROUND: Roll-out of Integrase Strand Transfer Inhibitors (INSTIs) such as dolutegravir for HIV combination antiretroviral therapy (cART) in sub-Saharan Africa necessitates the development of affordable HIV drug resistance (HIVDR) assays targeting the Integrase gene. We optimised and evaluated an...
Autores principales: | Seatla, Kaelo K., Choga, Wonderful T., Mogwele, Mompati, Diphoko, Thabo, Maruapula, Dorcas, Mupfumi, Lucy, Musonda, Rosemary M., Rowley, Christopher F., Avalos, Ava, Kasvosve, Ishmael, Moyo, Sikhulile, Gaseitsiwe, Simani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871785/ https://www.ncbi.nlm.nih.gov/pubmed/31751353 http://dx.doi.org/10.1371/journal.pone.0224292 |
Ejemplares similares
-
Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021) -
HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021) -
Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020) -
HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022) -
Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
por: Maruapula, Dorcas, et al.
Publicado: (2021)